REGENXBIO
RGNX
₹732.34
Share price
-4.32%
Change (1 day)
-39.06%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹18.87 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are ₹18.87 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹17.70 B | -18.91% |
| 2023-12-31 | ₹21.83 B | -16.8% |
| 2022-12-31 | ₹26.23 B | 0.83% |
| 2021-12-31 | ₹26.02 B | 7.69% |
| 2020-12-31 | ₹24.16 B | 610.23% |
| 2019-12-31 | ₹3.40 B | 39.16% |
| 2018-12-31 | ₹2.44 B | 144.7% |
| 2017-12-31 | ₹0.99 B | 33.72% |
| 2016-12-31 | ₹0.74 B | 145.91% |
| 2015-12-31 | ₹0.30 B | -47.83% |
| 2014-12-31 | ₹0.58 B | 102.59% |
| 2013-12-31 | ₹0.28 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹2.01 B | -89.33% | 🇺🇸 USA |